title: [Pathogen inactivation processes applicable to cellular products: the Canadian perspective].
abstract: The highlights of the recent Canadian consensus conference on pathogen inactivation are summarized. Also, a brief summary of steps taken to date in order to implement these technologies is presented.
authors.affiliation: Affaires médicales en microbiologie, Héma-Québec, Saint-Laurent, QC, Canada. gilles.delage@hema-quebec.qc.ca
authors.forename: G
authors.initials: G
authors.lastname: Delage
mesh_terms: D016913:Blood Component Transfusion / Q000009:adverse effects*; D017848:Blood-Borne Pathogens; D002170:Canada; D003245:Consensus Statements as Topic; D006801:Humans; D017053:Infection Control / Q000379:methods*